Patents Assigned to Renovis, Inc.
  • Use of aryl nitrone compounds in methods for treating neuropathic pain
    Patent number: 6835754
    Abstract: 3,4,5-trisubstituted aryl nitrone compounds having the formula: where R1-R4 are as defined in the specification are useful as therapeutics for neuropathic pain conditions in mammals.
    Type: Grant
    Filed: January 8, 2002
    Date of Patent: December 28, 2004
    Assignee: Renovis, Inc.
    Inventors: L. David Waterbury, Paul L. Wood, M. Amin Khan, Ravindra B. Upasani
  • Use of aryl nitrone compounds in methods for treating neuropathic pain
    Publication number: 20040209958
    Abstract: 3,4,5-trisubstituted aryl nitrone compounds having the formula: 1
    Type: Application
    Filed: May 12, 2004
    Publication date: October 21, 2004
    Applicant: RENOVIS, INC.
    Inventors: L. David Waterbury, Paul L. Wood, M. Amin Khan, Ravindra B. Upasani
  • 3,4,5-Trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
    Publication number: 20040198835
    Abstract: Disclosed are 3,4,5-trisubstituted aryl nitrone compoundsd and pharmaceutical compositions containing such compounds. The 3,4,5-trisubstituted aryl nitrone compounds have formula (I); where R1-R4 are as defined in the specification. The disclosed compositions are useful as therapeutics for inflammation-related conditions in mammals, such as arthritis, and as analytical reagents for detecting free radicals.
    Type: Application
    Filed: January 12, 2004
    Publication date: October 7, 2004
    Applicant: RENOVIS, INC.
    Inventors: L. David Waterbury, Allan L. Wilcox, John M. Carney, Farah Mavandadi, Albert Danielzadeh
  • Acetamidobenzamide compounds for neurodegenerative disorders
    Patent number: 6759433
    Abstract: A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.
    Type: Grant
    Filed: December 12, 2002
    Date of Patent: July 6, 2004
    Assignee: Renovis, Inc.
    Inventors: William Flitter, William Garland, Richard Paylor, Allan Wilcox
  • 3,4,5,-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
    Patent number: 6730700
    Abstract: Disclosed are 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing such compounds. The 3,4,5-trisubstituted aryl nitrone compounds have formula (I); where R1-R4 are as defined in the specification. The disclosed compositions are useful as therapeutics for inflammation-related conditions in mammals, such as arthritis, and as analytical reagents for detecting free radicals.
    Type: Grant
    Filed: July 15, 2002
    Date of Patent: May 4, 2004
    Assignee: Renovis, Inc.
    Inventors: L. David Waterbury, Allan L. Wilcox, John M. Carney, Farah Mavandadi, Albert Danielzadeh